Evidence map›Paper›PMID 27877717›Full record

ArticleScience and technology of advanced materials2014

Photoluminescence and doping mechanism of theranostic Eu

Min-Hua Chen, Tomohiko Yoshioka, Toshiyuki Ikoma, Nobutaka Hanagata, Feng-Huei Lin, Junzo Tanaka

Abstract read
In one paragraph

Article in Science and technology of advanced materials, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Pro-osteogenesis andBioactive materials · 2021
    Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Min-Hua ChenInstitute of Biomedical Engineering, National Taiwan University, Taipei, Taiwan; Department of Metallurgy and Ceramics Science, Tokyo Institute of Technology, Tokyo, Japan.
Tomohiko YoshiokaDepartment of Metallurgy and Ceramics Science, Tokyo Institute of Technology, Tokyo, Japan.
Toshiyuki IkomaDepartment of Metallurgy and Ceramics Science, Tokyo Institute of Technology, Tokyo, Japan.
Nobutaka HanagataNanotechnology Innovation Station, National Institute for Materials Science, Tsukuba, Japan.
Feng-Huei LinInstitute of Biomedical Engineering, National Taiwan University, Taipei, Taiwan; Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Miaoli County, Taiwan.
Junzo TanakaDepartment of Metallurgy and Ceramics Science, Tokyo Institute of Technology, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Theranostic nanoparticles currently have been regarded as an emerging concept of 'personalized medicine' with diagnostic and therapeutic dual-functions. Eu

Indexed as

Eu3+/Fe3+ doped-hydroxyapatitetheranostic nanoparticles and photoluminescence

Identifiers

PMID27877717
PMCPMC5099678

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.